NASDAQ$BTTC

Black Titan Corp · Q2 2014 earnings

Q2 2014 earnings · Reported Aug 13, 2014 (12 years ago) · Investor relations

Aug 13Jun 30, 2014

Total Revenue

$912K

Previous: -$120K+858.6%

EPS (adj)

-$0.30

Previous: $1.80-116.7%

Capital Expenditures

$8K

Previous: $118K-93.2%

Net Income

-$842K

Previous: -$102K-729.4%

Operating Income

-$550K

Previous: $30K-1930.7%

Gross Profit

$163K

Previous: $507K-67.9%

Cash & Equivalents

$8.85M

Previous: $288K+2973.5%

Total Assets

$14.2M

Previous: $7.78M+83.2%

Stock-Based Comp

$60K

Previous: $130K-53.8%

Titan Pharmaceuticals · Revenue · Quarterly

$912K

Q2 2014-858.6%vs Q2 2013

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation